Prevention of type 2 diabetes: The strategic approach for implementation

Hormone and Metabolic Research

Volumn 43, Issue 13, 2011, Pages 907-910

  Schwarz, P E H ^a   Albright, A L ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

diabetes prevention; global diabetes survey; implementation; public health; type 2 diabetes; visceral fat

Indexed keywords

ARTICLE; DIETARY INTAKE; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; KNOWLEDGE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH; SCREENING;

DIABETES MELLITUS, TYPE 2; HUMANS; PREVENTIVE MEDICINE; WORLD HEALTH;

EID: 83155180146     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1295462     Document Type: Article

References (30)

1. Schwarz P E, Li J, Reimann M, Schutte A E, Bergmann A, Hanefeld M et al. The Finnish Diabetes Risk Score Is Associated with Insulin Resistance and Progression towards Type 2 Diabetes. J Clin Endocrinol Metab: 2009; 94 920 926
2. Reimann M, Schutte A E, Schwarz P E. Insulin resistance the role of ethnicity: evidence from Caucasian and African cohorts. Horm Metab Res: 2007; 39 853 857
3. Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O et al. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res: 2006; 38 178 182
4. Wareham N J, Byrne C D, Williams R, Day N E, Hales C N. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care: 1999; 22 262 270 (Pubitemid 29056920)
5. Speliotes E K, Willer C J, Berndt S I, Monda K L, Thorleifsson G, Jackson A U et al. Association analyses of 249796 individuals reveal 18 new loci associated with body mass index. Nat Genet: 2010; 42 937 948
6. Ingelsson E, Langenberg C, Hivert M F, Prokopenko I, Lyssenko V, Dupuis J et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes: 2010; 59 1266 1275
7. Laaksonen D E, Siitonen N, Lindstrom J, Eriksson J G, Reunanen P, Tuomilehto J et al. Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism. Med Sci Sports Exerc: 2007; 39 227 232 (Pubitemid 46204288)
8. Florez J C, Jablonski K A, Bayley N, Pollin T I, de Bakker P I, Shuldiner A R et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med: 2006; 355 241 250 (Pubitemid 44079339)
9. Lindstrom J, Peltonen M, Eriksson J G, Aunola S, Hamalainen H, Ilanne-Parikka P et al. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care: 2008; 31 857 862
10. Knowler W C, Barrett-Connor E, Fowler S E, Hamman R F, Lachin J M, Walker E A et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med: 2002; 346 393 403 (Pubitemid 34437694)
11. Tuomilehto J, Lindstrom J, Eriksson J G, Valle T T, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med: 2001; 344 1343 1350 (Pubitemid 32378388)
12. Schwarz P E, Reimann M, Li J, Bergmann A, Licinio J, Wong M L et al. The metabolic syndrome a global challenge for prevention. Horm Metab Res: 2007; 39 777 780 (Pubitemid 350206897)
13. Schwarz P E, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res: 2009; 41 86 97
14. Saaristo T, Peltonen M, Keinnen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L. et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health: 2007; 66 101 112
15. Albright A, Williamson D F. Community Approaches to Diabetes Prevention. In: LeRoith D. (ed) Prevention of Type 2 diabetes; From Science to Therapies. Vol 1 New York Springer: 2011
16. Amundson H A, Butcher M K, Gohdes D, Hall T O, Harwell T S, Helgerson S D et al. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program. Diabetes Educ: 2009; 35 209 210 213204, 216220 passim
17. Ackermann R T, Finch E A, Brizendine E, Zhou H, Marrero D G. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med: 2008; 35 357 363
18. Kramer M K, Kriska A M, Venditti E M, Miller R G, Brooks M M, Burke L E et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med: 2009; 37 505 511
19. Schwarz P E, Schwarz J, Schuppenies A, Bornstein S R, Schulze J. Development of a diabetes prevention management program for clinical practice. Public Health Rep: 2007; 122 258 263
20. Schwarz P E, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo N C, Peltonen M et al. The European perspective of type 2 diabetes prevention: diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes: 2008; 116 167 172 (Pubitemid 351518536)
21. Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N. Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabet Med: 2010; 27 459 465
22. Paulweber B, Valensi P, Lindstrm J, Lalic N M, Greaves C J, McKee M et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res: 2010; 42 01 S3 S36
23. Lindstrom J, Neumann A, Sheppard K E, Gilis-Januszewska A, Greaves C J, Handke U et al. Take action to prevent diabetes the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res: 2010; 42 01 S37 S55
24. Pajunen P, Landgraf R, Muylle F, Neumann A, Lindstrom J, Schwarz P E et al. Quality indicators for the prevention of type 2 diabetes in Europe IMAGE. Horm Metab Res: 2010; 42 01 S56 S63
25. Rothe U, Muller G, Tselmin S, Odenbach C, Scheuch K, Koch R et al. Prevalence for the cluster of risk factors of the Metabolic Vascular Syndrome in a working population in Germany. Horm Metab Res: 2009; 41 168 170
26. Rothe U, Muller G, Schwarz P E, Seifert M, Kunath H, Koch R et al. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes Care: 2008; 31 863 868
27. Schwarz P E, Muylle F, Valensi P, Hall M. The European perspective of diabetes prevention. Horm Metab Res: 2008; 40 511 514
28. Onyegbutulem H C. PI HO Reimann M, Li J, Bornstein S R, Schwarz P E. Metabolic syndrome in Africa: an emerging perspective. Horm Metab Res: 2009; 41 75 78
29. Sinclair J C, Torrance G W, Boyle M H, Horwood S P, Saigal S, Sackett D L. Evaluation of neonatal-intensive-care programs. N Engl J Med: 1981; 305 489 494 (Pubitemid 11047416)
30. Detsky A S, Naglie I G. A clinicians guide to cost-effectiveness analysis. Ann Intern Med: 1990; 113 147 154